Clinical Trial Update: Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial) [Phase 2]

View source ↗

Summary

A Phase 2 trial (TRAP) evaluating ATR and PARP inhibition in resistant prostate cancer has posted results as of 2024-08-12; the study is active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-08-12